Inhibitory effects of platinum anticancer agents on rat brain protein kinase C.
Sharma
P
P
Interdisciplinary Research Centre for Cell Modulation Studies, Faculty of Health and Science, University of East London, UK.
Bach
P H
PH
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001921:Brain / Q000201:enzymology*; D016190:Carboplatin / Q000494:pharmacology; D002945:Cisplatin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D008297:Male; D009944:Organoplatinum Compounds / Q000494:pharmacology; D010984:Platinum / Q000494:pharmacology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors* / Q000302:isolation & purification; D051381:Rats; D017208:Rats, Wistar
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D009944:Organoplatinum Compounds; D010984:Platinum; C023359:iproplatin; C081294:satraplatin; D016190:Carboplatin; D011493:Protein Kinase C; D002945:Cisplatin